BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15246568)

  • 1. Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Keohavong P; Gao WM; Mady HH; Kanbour-Shakir A; Melhem MF
    Cancer Lett; 2004 Aug; 212(1):121-30. PubMed ID: 15246568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
    Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ
    Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
    Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL
    Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S; Wei B; Zhang H; Qing M; Bu H
    Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
    Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL
    J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
    Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
    J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Lodato RF; Maguire HC; Greene MI; Weiner DB; LiVolsi VA
    Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.
    Dunlap J; Le C; Shukla A; Patterson J; Presnell A; Heinrich MC; Corless CL; Troxell ML
    Breast Cancer Res Treat; 2010 Apr; 120(2):409-18. PubMed ID: 19418217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of critical genetic changes in human breast disease.
    Ellsworth RE; Ellsworth DL; Deyarmin B; Hoffman LR; Love B; Hooke JA; Shriver CD
    Ann Surg Oncol; 2005 Dec; 12(12):1054-60. PubMed ID: 16228814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
    Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
    Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 protein expression and nuclear DNA content in breast intraductal proliferations.
    Schmitt FC; Leal C; Lopes C
    J Pathol; 1995 Jul; 176(3):233-41. PubMed ID: 7674086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clonality of the peripheral papilloma and cancerous cells of breast].
    Niu Y; Yu Q; Yu Y; Ding XM; Shi YR
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):542-5. PubMed ID: 17459204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
    Gobbi H; Jensen RA; Simpson JF; Olson SJ; Page DL
    Hum Pathol; 2001 Aug; 32(8):785-90. PubMed ID: 11521220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
    Pollett A; Bedard YC; Li SQ; Rohan T; Kandel R
    Mod Pathol; 2000 Nov; 13(11):1173-9. PubMed ID: 11106073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
    J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the progression of intraductal proliferative lesions in the breast by PCR-based clonal assay.
    Yu Q; Niu Y; Yu Y; Ding X; Shi Y
    Breast Cancer Res Treat; 2009 Apr; 114(3):433-40. PubMed ID: 18425676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.